PEOPLE - Exagen Diagnostics makes appointment:
This article was originally published in Clinica
Exagen Diagnostics (Albuquerque, New Mexico), a specialist in genomic marker-based IVD kits targeting treatment responses, has appointed Thomas Williams, a special advisor for molecular pathology, to chief scientific officer and vice-president for R&D. Dr Williams, who retains his post as part-time professor of pathology at the University of New Mexico, was formerly the department's vice-chairman, and director of New Mexico-based TriCore Reference Laboratories' genetics and cytometry division.
You may also be interested in...
A collaboration between Novo and Fauna will look at animal hibernation and genetic sequencing for hints toward novel therapies for obesity. Pfizer will use Insilico’s machine learning technology in target validation.